BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22237726)

  • 1. Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Orui H; Fukuda S; Yoneda K; Okumura Y; Tsubota N; Fukuoka K; Torii I; Tsujimura T; Nakano T
    Int J Clin Oncol; 2012 Feb; 17(1):33-9. PubMed ID: 22237726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant pleural diseases: diagnosis and treatment].
    Cicenas S; Vencevicius V
    Medicina (Kaunas); 2008; 44(12):929-35. PubMed ID: 19142050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
    Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
    BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
    Soysal O; Karaoğlanoğlu N; Demiracan S; Topçu S; Taştepe I; Kaya S; Unlü M; Cetin G
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):210-3. PubMed ID: 9080144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.
    Davies HE; Nicholson JE; Rahman NM; Wilkinson EM; Davies RJ; Lee YC
    Eur J Cardiothorac Surg; 2010 Oct; 38(4):472-7. PubMed ID: 20219385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical therapy of malignant pleural mesothelioma].
    Schirren M; Sponholz S; Oguzhan S; Fisseler-Eckhoff A; Fischer A; Schirren J
    Chirurg; 2016 May; 87(5):455-66. PubMed ID: 27169584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.
    Franceschini MC; Ferro P; Canessa PA; Battolla E; Dessanti P; Valentino A; Casolari L; Fontana V; Pezzi R; Fedeli F; Pistillo MP; Roncella S
    Anticancer Res; 2014 Dec; 34(12):7425-9. PubMed ID: 25503183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of malignant mesothelioma controlled by pleurectomy].
    Kishimoto T; Sato T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Nov; 30(11):1996-2001. PubMed ID: 1484440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological and molecular biological approaches to early mesothelioma.
    Tsujimura T; Torii I; Sato A; Song M; Fukuoka K; Hasegawa S; Nakano T
    Int J Clin Oncol; 2012 Feb; 17(1):40-7. PubMed ID: 22237727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
    Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
    J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
    Segal A; Sterrett GF; Frost FA; Shilkin KB; Olsen NJ; Musk AW; Nowak AK; Robinson BW; Creaney J
    Pathology; 2013 Jan; 45(1):44-8. PubMed ID: 23222247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.
    Bueno R; Reblando J; Glickman J; Jaklitsch MT; Lukanich JM; Sugarbaker DJ
    Ann Thorac Surg; 2004 Nov; 78(5):1774-6. PubMed ID: 15511473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.
    Canessa PA; Franceschini MC; Ferro P; Battolla E; Dessanti P; Manta C; Sivori M; Pezzi R; Fontana V; Fedeli F; Pistillo MP; Roncella S
    Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the best way to diagnose and stage malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
    Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
    Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma.
    Kent M; Rice D; Flores R
    Curr Treat Options Oncol; 2008 Jun; 9(2-3):158-70. PubMed ID: 18758965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and staging of malignant pleural mesothelioma].
    Sohrab S; Konietzko N
    Pneumologie; 2002 Jun; 56(6):382-7. PubMed ID: 12063622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of malignant mesothelioma showing rapid progression during one month].
    Hara H; Tamura A; Suzuki J; Masuda K; Nagai H; Akagawa S; Kawabe Y; Nagayama N; Machida K; Kurashima A; Sagara Y; Komatsu H; Yotsumoto H; Hebisawa A; Kimura A
    Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):417-21. PubMed ID: 16050468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of malignant pleural mesothelioma.
    Yanagawa J; Rusch V
    Thorac Surg Clin; 2013 Feb; 23(1):73-87, vi. PubMed ID: 23206719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
    Paintal A; Raparia K; Zakowski MF; Nayar R
    Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.